Literature DB >> 10523160

Endocarditis due to Streptococcus mitis with high-level resistance to penicillin and cefotaxime.

J R Lonks, B P Dickinson, V Runarsdottir.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523160     DOI: 10.1056/NEJM199910143411616

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002.

Authors:  Rajesh M Prabhu; Kerryl E Piper; Larry M Baddour; James M Steckelberg; Walter R Wilson; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.

Authors:  C Garcia-de-la-Maria; Y Q Xiong; J M Pericas; Y Armero; A Moreno; N N Mishra; M J Rybak; T T Tran; C A Arias; P M Sullam; A S Bayer; J M Miro
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

3.  Mitral Valve Replacement Under Venoarterial Extracorporeal Membrane Oxygenation Support for Severe Streptococcus Mitis Endocarditis.

Authors:  Talha Ahmed; Marianne Wallis
Journal:  Cureus       Date:  2020-04-06

4.  Dual functions of discoidinolysin, a cholesterol-dependent cytolysin with N-terminal discoidin domain produced from Streptococcus mitis strain Nm-76.

Authors:  Atsushi Tabata; Airi Matsumoto; Ai Fujimoto; Kazuto Ohkura; Takuya Ikeda; Hiroki Oda; Shuto Yokohata; Miho Kobayashi; Toshifumi Tomoyasu; Ayuko Takao; Hisashi Ohkuni; Hideaki Nagamune
Journal:  J Oral Microbiol       Date:  2022-08-01       Impact factor: 5.833

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.